Pathophysiology of pulmonary aspergillosis

Journal of Infection and Chemotherapy

Volumn 10, Issue 3, 2004, Pages 138-145

  Shibuya, Kazutoshi ^a   Ando, Tsunehiro ^b   Hasegawa, Chikako ^a   Wakayama, Megumi ^c   Hamatani, Shigeharu ^a   Hatori, Tsutomu ^a   Nagayama, Tadashi ^a   Nonaka, Hiroko ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Histopathology; HIV; Leukemia; Neutropenia; Neutrophile; Pulmonary aspergillosis

Indexed keywords

ASPERGILLUS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEFENSE MECHANISM; FUNGAL VIRULENCE; HISTOPATHOLOGY; HUMAN; LUNG ASPERGILLOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

EID: 3843104538     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0315-5     Document Type: Review

References (32)

1. Shibuya K, Coulson WF, Naoe S. Histopathology of deep-seated fungal infection and detailed examination of granulomatous response against cryptococci in patients with acquired immunodeficiency syndrome. Jpn J Med Mycol 2002;43:143-51.
2. Wakayama M, Shibuya K, Ando T, Oharaseki T, Takahashi K, Naoe S, et al. Deep-seated mycosis as a complication in bone marrow transplantation patients. Mycoses 2002;45:146-51.
3. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001;33:641-7.
4. Shibuya K, Ando T, Wakayama M, Takaoka M, Uchida K, Naoe S. Pathological spectrum of invasive pulmonary aspergillosis: Study of pulmonary lesions of 54 autopsies and the relationship between neutrophilic response and histologic features of lesions in experimental aspergillosis. Jpn J Med Mycol 1997;38:175-81.
5. Shibuya K, Yamaguchi Y, Naoe S. Animal models of A. fumigatus infections. In: Brakhage AA, Jahn B, Schmidt A, editors. Aspergillus fumigatus, contribution to microbiology, vol 2. Basel: Karger; 1999. p. 130-8.
6. Gefter WB. The spectrum of pulmonary aspergillosis, J Thorac Imaging 1992;7:56-74.
7. Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: A discrete clinical entity, Medicine 1982;61:109-24.
8. Shibuya K, Takaoka M, Uchida K, et al. Histopathology of experimental invasive pulmonary aspergillosis in rats: Pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants. Microbiol Pathog 1999;27:123-31.
9. Shibuya K. Chest radiographs closely mirror pulmonary Aspergillosis, recognizing image patterns can improve estimate of prognosis. Mycology observer 2001;10:6-7.
10. Caillot D, Casanovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47.
11. Raper KB, Fennel DI. The genus Aspergillus, Williams & Wilkins, Baltimore, 1965.
12. Kwon-Chung KJ, Bennett JE. Medical Mycology, Lea & Febiger, Philadelphia, 1992.
13. Guiot HFL, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:525-32.
14. Smith JM, Tang CM, Van Noorden S, Holden DW. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun 1994;62:5247-54.
15. Miyaji M, Yamaguchi H. Animal models in medical mycology, CRC, Boca Raton, Florida, 1987.
16. Ford S, Friedman L. Experimental study of the pathogenecity of Aspergilli for mice. J Bacteriol 1967;94:928-33.
17. Niki Y, Bernard EM, Edwards FF, Schmitt HJ, Yu B, Armstrong D. Model of recurrent pulmonary aspergillosis in rats. J Clin Microbiol 1991;29:1317-22.
18. Berenguer J, Allende MC, Lee W, Garrett K, Lyman C, Ali NM. Pathogenesis of pulmonary aspergillosis: granulocytopenia versus cyclosporin and methylpredonisoloe-induced immunosuppression. Am J Respir Crit Care Med 1995;152:1079-86.
19. Jensen HE, Aalbaek B, Hau J, Latge JP. Detection of galactomannan and complement activation in the pregnant mouse during experimental systemic aspergillosis. APMIS 1996;104:926-32.
20. Tang CM, Cohen J, Krausz T, Van Noorden S, Holden DW. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun 1993;61:1650-6.
21. Mellado E, Specht CA, Robbins PW, Holden DW. Cloning and characterization of chsD, a chitin synthase-like gene of Aspergillus fumigatus. FEMS Microbiol Lett 1996;143:69-76.
22. Mondon P, De Champs C, Donadille A, Ambroise-Thomas P, Grillot R. Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis. J Med Microbiol 1996;45:186-91.
23. Frosco MB, Chase T Jr, Macmillan JD. The effect of elastase-specific monoclonal and polyclonal antibodies on the virulence of Aspergillus fumigatus in immunocompromised mice. Mycopathologia 1994;125:65-76.
24. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997;185:1089-99.
25. Murali PS, Kurup VP, Guo J, Fink JN. Development of bone marrow eosinophilia in mice induced by Aspergillus fumigatus antigens. Clin Immunol Immunopathol 1997;84:216-20.
26. George D, Miniter P, Andriole VT. Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother 1996;40:86-91.
27. Berenguer J, Ali NM, Allende MC, Lee J, Garrett K, Battaglia S, et al. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma. Antimicrob Agents Chemother 1994;38:1303-8.
28. de Repentigny L, Kilanowski E, Pedneault L, Boushira M. Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis. J Infect Dis 1991;163:1305-11.
29. Chilvers ER, Spreadbury CL, Cohen J. Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive pulmonary aspergillosis. Mycopathologia 1989;108:163-71.
30. McGuire TW, Bullock JD, Bullock JD Jr, Elder BL, Funkhouser JW. Fungal endophthalmitis. An experimental study with a review of 17 human ocular cases. Arch Ophthalmol 1991;109:1289-96.
31. Cicogna CE, White MH, Bernard EM, Ishimura T, Sun M, Tong WP, et al. Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis. Antimicrob Agents Chemother 1997;41:259-61.
32. Kurtz MB, Bernard EM, Edwards FF, Marrinan JA, Dropinski J, Douglas CM, et al. Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis. Antimicrob Agents Chemother 1995;39:1784-9.